A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers

NCT01684891 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hoffmann-La Roche